{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:45:18Z","timestamp":1762505118845},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,7,1]]},"DOI":"10.1093\/rheumatology\/kel075","type":"journal-article","created":{"date-parts":[[2006,3,10]],"date-time":"2006-03-10T01:48:34Z","timestamp":1141955314000},"page":"787-789","source":"Crossref","is-referenced-by-count":43,"title":["Drug-related pulmonary problems in patients with rheumatoid arthritis"],"prefix":"10.1093","volume":"45","author":[{"given":"V.","family":"Saravanan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,3,9]]},"reference":[{"key":"key\n\t\t\t\t20171012052024_BIB1","unstructured":"Committee on Safety of Medicines. Methotrexate and pneumonitis: new recommendations on monitoring for pulmonary symptoms. Curr Probl Pharmacovigilance2003;29:5."},{"key":"key\n\t\t\t\t20171012052024_BIB2","unstructured":"National Patient Safety Agency. Methotrexate: patient information leaflet. London: NPSA,2004."},{"key":"key\n\t\t\t\t20171012052024_BIB3","doi-asserted-by":"crossref","unstructured":"Ito S, Sumida T. Interstitial lung disease associated with leflunomide. Intern Med2004;43:1103\u20134.","DOI":"10.2169\/internalmedicine.43.1103"},{"key":"key\n\t\t\t\t20171012052024_BIB4","doi-asserted-by":"crossref","unstructured":"Kamata Y, Nara H, Kamimura T et al. Rheumatoid arthritis complicated with acute interstitial pneumonia induced by leflunomide as an adverse reaction. Intern Med2004;43:1201\u20134.","DOI":"10.2169\/internalmedicine.43.1201"},{"key":"key\n\t\t\t\t20171012052024_BIB5","doi-asserted-by":"crossref","unstructured":"McCurry J. Japan deaths spark concerns over arthritis drug. Lancet2004;363:461.","DOI":"10.1016\/S0140-6736(04)15527-X"},{"key":"key\n\t\t\t\t20171012052024_BIB6","unstructured":"Takeishi M, Akiyama Y, Akiba H, Adachi D, Hirano M, Mimura T. Leflunomide induced acute interstitial pneumonia. J Rheumatol2005;32:1160\u20133."},{"key":"key\n\t\t\t\t20171012052024_BIB7","doi-asserted-by":"crossref","unstructured":"Ostor A, Crisp A, Somerville M, Scott D. Fatal exacerbation of rheumatoid arthritis associated fibrosing alveolitis in patients given infliximab. BMJ2004;329:1266.","DOI":"10.1136\/bmj.329.7477.1266"},{"key":"key\n\t\t\t\t20171012052024_BIB8","doi-asserted-by":"crossref","unstructured":"Ellman P, Ball RE. Rheumatoid disease with joint and pulmonary manifestations. B Med J1948;2:816\u201320.","DOI":"10.1136\/bmj.2.4583.816"},{"key":"key\n\t\t\t\t20171012052024_BIB9","doi-asserted-by":"crossref","unstructured":"Kelly CA. Rheumatoid arthritis: classical rheumatoid lung disease. Baillieres Clin Rheumatol1993;7:1\u201316.","DOI":"10.1016\/S0950-3579(05)80265-1"},{"key":"key\n\t\t\t\t20171012052024_BIB10","doi-asserted-by":"crossref","unstructured":"Dawson JK, Fewins HE, Desmond J, Lynch MP, Graham DR. Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests. Thorax2001;56:622\u20137.","DOI":"10.1136\/thorax.56.8.622"},{"key":"key\n\t\t\t\t20171012052024_BIB11","doi-asserted-by":"crossref","unstructured":"Hassan WU, Keaney NP, Holland CD, Kelly CA. Bronchial reactivity and airflow obstruction in rheumatoid arthritis. Ann Rheum Dis1994;53:511\u20134.","DOI":"10.1136\/ard.53.8.511"},{"key":"key\n\t\t\t\t20171012052024_BIB12","unstructured":"Saravanan V, Cox J, Keaney NP, Kelly CA. Airway obstruction rheumatoid arthritis: correlation with articular disease. Rheumatology2003;42:48(A85)."},{"key":"key\n\t\t\t\t20171012052024_BIB13","unstructured":"Thomas E, Symmons DP, Brewster DH, Black RJ, Macfarlane GJ. National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20 year followup study. J Rheumatol2003;30:958\u201365."},{"key":"key\n\t\t\t\t20171012052024_BIB14","unstructured":"Coyne P, Doe S, Saravanan V, Heycock C, Hamilton J, Kelly CA. Is respiratory infection in patients with rheumatoid arthritis caused by disease modifying drugs? Rheumatology2005;44:i74(A42)."},{"key":"key\n\t\t\t\t20171012052024_BIB15","doi-asserted-by":"crossref","unstructured":"Grove ML, Hassell AB, Hay EM, Shadforth MF. Adverse reactions to disease-modifying anti-rheumatic drugs in clinical practice. 2001;94:309\u201319.","DOI":"10.1093\/qjmed\/94.6.309"},{"key":"key\n\t\t\t\t20171012052024_BIB16","doi-asserted-by":"crossref","unstructured":"Imokawa S, Colby TV, Leslie KO, Helmers RA. Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. Eur Respir J2000;15:373\u201381.","DOI":"10.1034\/j.1399-3003.2000.15b25.x"},{"key":"key\n\t\t\t\t20171012052024_BIB17","doi-asserted-by":"crossref","unstructured":"Kinder AJ, Hassell AB, Brand J, Brownfield A, Grove M, Shadforth MF. The treatment of inflammatory arthritis with methotrexate in clinical practice: treatment duration and incidence of adverse drug reactions. Rheumatology2005;44:61\u20136.","DOI":"10.1093\/rheumatology\/keh512"},{"key":"key\n\t\t\t\t20171012052024_BIB18","doi-asserted-by":"crossref","unstructured":"Alarcon GS, Kremer JM, Macaluso M et al. Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. A multicenter, case-control study. Methotrexate-Lung Study Group. Ann Intern Med1997;127:356\u201364.","DOI":"10.7326\/0003-4819-127-5-199709010-00003"},{"key":"key\n\t\t\t\t20171012052024_BIB19","unstructured":"Howes M, Tose J, White C, Kumar N, Heycock C, Kelly CA. Can baseline pulmonary functions tests predict pulmonary toxicity in patients receiving methotrexate for rheumatoid arthritis? Intern Med1999;7:51\u20134."},{"key":"key\n\t\t\t\t20171012052024_BIB20","unstructured":"Searles G, McKendry RJ. Methotrexate pneumonitis in rheumatoid arthritis: potential risk factors. Four case reports and a review of the literature. J Rheumatol1987;14:1164\u201371."},{"key":"key\n\t\t\t\t20171012052024_BIB21","doi-asserted-by":"crossref","unstructured":"Macfarlane JT, Boldy D. 2004 update of BTS pneumonia guidelines: what's new? Thorax2004;59:364\u20136.","DOI":"10.1136\/thx.2004.024992"},{"key":"key\n\t\t\t\t20171012052024_BIB22","doi-asserted-by":"crossref","unstructured":"Gluck T. Vaccinate your immunocompromised patients! Rheumatology2006;45:9\u201310.","DOI":"10.1093\/rheumatology\/kei237"},{"key":"key\n\t\t\t\t20171012052024_BIB23","doi-asserted-by":"crossref","unstructured":"Kapetanovic MC, Saxne T, Sjoholm A, Truedsson L, Jonsson G, Geborek P. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology2006;45:106\u201311.","DOI":"10.1093\/rheumatology\/kei193"},{"key":"key\n\t\t\t\t20171012052024_BIB24","doi-asserted-by":"crossref","unstructured":"Saravanan V, Kelly CA. Reducing the risk of methotrexate pneumonitis in rheumatoid arthritis. Rheumatology2004;43:143\u20137.","DOI":"10.1093\/rheumatology\/keg466"},{"key":"key\n\t\t\t\t20171012052024_BIB25","doi-asserted-by":"crossref","unstructured":"Ledingham J, Deighton C. Update on the British Society for Rheumatology guidelines for prescribing TNF\u03b1 blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001). Rheumatology2005;44:157\u201363.","DOI":"10.1093\/rheumatology\/keh464"},{"key":"key\n\t\t\t\t20171012052024_BIB26","doi-asserted-by":"crossref","unstructured":"Peno-Green L, Lluberas G, Kingsley T, Brantley S. Lung injury linked to etanercept therapy. Chest2002;122:1858\u201360.","DOI":"10.1378\/chest.122.5.1858"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/45\/7\/787\/9448496\/kel075.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T07:56:30Z","timestamp":1555487790000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/rheumatology\/article\/45\/7\/787\/1788784\/Drugrelated-pulmonary-problems-in-patients-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,9]]},"references-count":26,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2006,3,9]]},"published-print":{"date-parts":[[2006,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/kel075","relation":{},"ISSN":["1462-0332","1462-0324"],"issn-type":[{"value":"1462-0332","type":"electronic"},{"value":"1462-0324","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,7]]},"published":{"date-parts":[[2006,3,9]]}}}